Real-World Evidence (RWE): The need for a multi-stakeholder approach
Listen now
Description
SOUNDS OF SCIENCE - EPISODE 17 On this episode, we explore the topic of Real-World Data and Real-World Evidence – that is data that is collected in a real-world setting, such as in healthcare institutions rather than through controlled experiments. We examine how and why this information can be useful for biopharma companies and health authorities, in order to bring new innovative therapies to patients. We will also look into some of the challenges with using this type of data, and view how a multi-stakeholder initiative - RWE4Decisions - is tackling those issues. Our special guests include: Karen Facey, Senior Advisor HTA, RWE4Decisions Carlos Martin Saborido, Scientific Officer, Spanish Ministry of Health Alexander Natz, Secretary General, EUCOPE =================================================================================================================== For more information on EUCOPE’s initiatives with Real-World Evidence or how your organisation can contribute to it, please contact Matias Olsen [email protected] If your company would like to put forward a topic for us to discuss or to participate in a future podcast episode, please reach out to our producer, Dante Di Iulio.
More Episodes
Published 08/18/23
EUCOPE's Sounds of Science - Episode 16 On today’s episode, we explore the revision of the Orphan Medicinal Products (OMP) Regulation as part of the Pharmaceutical Package, and its impact on small and mid-sized pharmaceutical companies, the key drivers of innovation in Europe. We’d like to...
Published 07/11/23
SOUNDS OF SCIENCE - EPISODE 15 On today’s episode, we focus on the EU’s Medical Device Regulation (MDR) which came into full effect on 26 May 2021 and followed by the In Vitro Diagnostic Device Regulation (IVDR) the following year. The idea of both regulations is to balance the regulatory review...
Published 04/10/23